Acquazzino, Melissa A <br/><br/>
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.  [electronic resource] 

 -  Pediatric transplantation  Aug 2013 
 - 466-71 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-3046 
<br/><br/><label>Standard No.: </label>10.1111/petr.12101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Hemolytic, Autoimmune--etiology<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Calcineurin--metabolism<br/>Cyclophosphamide--therapeutic use<br/>Cyclosporine--therapeutic use<br/>Everolimus<br/>Female<br/>Hemolysis<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppression Therapy--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Infant<br/>Intestines--transplantation<br/>Liver Transplantation--adverse effects<br/>Male<br/>Medical Records<br/>Nephrotic Syndrome--etiology<br/>Pancreas Transplantation--adverse effects<br/>Penicillins--therapeutic use<br/>Plasmapheresis<br/>Retrospective Studies<br/>Rituximab<br/>Sirolimus--analogs & derivatives<br/>Steroids--therapeutic use<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Tacrolimus--therapeutic use<br/>Transplantation--adverse effects<br/>Treatment Outcome